SCHEMBL1811673

SCHEMBL1811673

NCCc1ccc(B(O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F11 P03951 1/20 0.64
LPL P06858 6/20 0.61
LIPG Q9Y5X9 6/20 0.61
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
TAAR1 Q96RJ0 7/20 0.56
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
HTR1A P08908 1/20 0.56
ADRA2A P08913 1/20 0.56
SLC6A2 P23975 1/20 0.56
CYP2C19 P33261 1/20 0.56
HTR3A P46098 1/20 0.56
BACE1 P56817 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
BLM P54132 1/20 0.54
KMT2A Q03164 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
TRPV1 Q8NER1 1/20 0.53
MGLL Q99685 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4008745 0.98 F11 (0.68) F11LPLLIPGCA1CA2
SCHEMBL890400 0.85 LPL (0.73) F11LPLLIPGCA1CA2
SCHEMBL1315421 0.81 LPL (0.61) F11LPLLIPGCA1CA2
SCHEMBL103171 0.80 F11 (0.95) F11LPLLIPGCA1CA2
SCHEMBL15981478 0.80 CA1 (0.52) F11LPLLIPGCA1CA2
SCHEMBL224548 0.79 TAAR1 (0.72) CA1CA2TAAR1KDM4EALDH1A1
SCHEMBL14756814 0.78 CA1 (0.50) F11LPLLIPGCA1CA2
SCHEMBL1421586 0.78 LPL (0.64) F11LPLLIPGCA1CA2
Hydrochloric Acid SCHEMBL721501 0.78 F11 (1.00) F11LPLLIPGCA1CA2
SCHEMBL21384773 0.77 CA1 (0.64) F11LPLLIPGCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116813381-B Biological ceramic surface bioactive coating and preparation method thereof 化学与精细化工广东省实验室潮州分中心 2024-12-03 CN claimed
CN-116925445-A Flame-retardant chloroprene rubber with double-network structure and preparation method thereof 安徽忠德输送工程技术有限公司 2023-10-24 CN claimed
CN-116813381-A Biological ceramic surface bioactive coating and preparation method thereof 化学与精细化工广东省实验室潮州分中心 2023-09-29 CN claimed
US-11110119-B2 Bi-functional co-polymer use for ophthalmic and other topical and local applications CALM WATER THERAPEUTICS LLC (US) 2021-09-07 US claimed
US-20200352984-A1 Bi-Functional Co-Polymer Use for Ophthalmic and Other Topical and Local Applications CALM WATER THERAPEUTICS LLC 2020-11-12 US claimed
US-10729715-B2 Bi-functional co-polymer use for ophthalmic and other topical and local applications EYEON PARTICLE SCIENCES LLC (US) 2020-08-04 US claimed
US-20180161363-A1 Bi-Functional Co-Polymer Use for Ophthalmic and Other Topical and Local Applications CALM WATER THERAPEUTICS LLC 2018-06-14 US claimed
US-9884074-B2 Bi-functional co-polymer use for ophthalmic and other topical and local applications EYEON PARTICLE SCIENCES LLC (US) 2018-02-06 US claimed
EP-3246048-A1 BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS Eyeon Particle Sciences LLC (US) 2017-11-22 EP claimed
US-20160243156-A1 Bi-Functional Co-Polymer Use for Ophthalmic and Other Topical and Local Applications CALM WATER THERAPEUTICS LLC 2016-08-25 US claimed
US-9283248-B2 Bi-functional co-polymer use for ophthalmic and other topical and local applications EYEON PARTICLE SCIENCES LLC (US) 2016-03-15 US claimed
US-7029688-B2 Methods and compositions to prevent formation of adhesions in biological tissues CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-04-18 US claimed
EP-1009451-B1 COMPOSITIONS AND THEIR USE TO PREVENT FORMATION OF ADHESIONS IN BIOLOGICAL TISSUES CALIFORNIA INST OF TECHN (US) 2003-10-29 EP claimed
US-20030185787-A1 Methods and compositions to prevent formation of adhesions in biological tissues CALIFORNIA INSTITUTE OF TECHNOLOGY 2003-10-02 US claimed
US-6596267-B1 Such as ethylene glycol-phenylboronic acid copolymer; prosthetics and implant coatings; readily adsorbs onto body tissues in situ providing steric barrier minimizing post-operative adhesion CALIFORNIA INSTITUTE OF TECHNOLOGY 2003-07-22 US claimed
EP-1009451-A2 METHODS AND COMPOSITIONS TO PREVENT FORMATION OF ADHESIONS IN BIOLOGICAL TISSUES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-06-21 EP claimed
WO-1999010022-A2 METHODS AND COMPOSITIONS TO PREVENT FORMATION OF ADHESIONS IN BIOLOGICAL TISSUES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1999-03-04 WO claimed
US-12195446-B2 Heteroaryl compounds and their use as therapeutic drugs DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2025-01-14 US disclosed
WO-2000012146-A1 GELS AND MULTILAYER SURFACE STRUCTURES FROM BORONIC ACID CONTAINING POLYMERS EIDGENÖSSISCH TECHNISCHE HOCHSCHULE ZURICH (CH) 2000-03-09 WO disclosed
WO-1999010022-A2 METHODS AND COMPOSITIONS TO PREVENT FORMATION OF ADHESIONS IN BIOLOGICAL TISSUES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1999-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12195446-B2 Heteroaryl compounds and their use as therapeutic drugs MERTK, ERBB2, SRC F11 4768/4885LPL 3708/4885LIPG 1899/4885
US-20030185787-A1 Methods and compositions to prevent formation of adhesions in biological tissues ITGB6, ITGA6, EPCAM F11 322/4885LPL 1758/4885LIPG 831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.